Evidence map›Paper›PMID 40434923›Full record

ArticleBioinformatics (Oxford, England)2025

Residue conservation and solvent accessibility are (almost) all you need for predicting mutational effects in proteins.

Matsvei Tsishyn, Pauline Hermans, Marianne Rooman, Fabrizio Pucci

Abstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Dissecting the effects of single amino acid substitutions in SARS-CoV-2 Mpro.Protein science : a publication of the Protein Society · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Matsvei TsishynComputational Biology and Bioinformatics, Université Libre de Bruxelles, Brussels 1050, Belgium.
Pauline HermansComputational Biology and Bioinformatics, Université Libre de Bruxelles, Brussels 1050, Belgium.
Marianne RoomanComputational Biology and Bioinformatics, Université Libre de Bruxelles, Brussels 1050, Belgium.
Fabrizio PucciComputational Biology and Bioinformatics, Université Libre de Bruxelles, Brussels 1050, Belgium.ORCID 0000-0003-2916-022X

Funding

Belgian Fund for Scientific Research
6 · The paper itself

Abstract

motivationPredicting how mutations impact protein biophysical properties remains a significant challenge in computational biology. In recent years, numerous predictors, primarily deep learning models, have been developed to address this problem; however, issues such as their lack of interpretability and limited accuracy persist.

resultsWe showed that a simple evolutionary score, based on the log-odd ratio of wild-type and mutated residue frequencies in evolutionary related proteins, when scaled by the residue's relative solvent accessibility, performs on par with or slightly outperforms most of the benchmarked predictors, many of which are considerably more complex. The evaluation is performed on mutations from the ProteinGym deep mutational scanning dataset collection, which measures various properties such as stability, activity or fitness. This raises further questions about what these complex models actually learn and highlights their limitations in addressing prediction of mutational landscape. AVAILABILITY AND IMPLEMENTATION: The RSALOR model is available as a user-friendly Python package that can be installed from the PyPI repository. The code is freely available at https://github.com/3BioCompBio/RSALOR.

Indexed as

Computational BiologyMutationProteinsSolventsDatabases, ProteinEvolution, MolecularSoftwareProteinsSolvents

Identifiers

PMID40434923
PMCPMC12202862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.